Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Editors Pick
    • Abbot Labs decision...

    Abbot Labs decision to outsource IT jobs to India faces criticism

    Written by Geeta Sharma Sharma Published On 2016-03-02T17:33:50+05:30  |  Updated On 2 March 2016 5:33 PM IST
    Abbot Labs  decision to outsource IT jobs to India faces criticism


    Temecula:A recent decision by Abbott Laboratories, a Chicago based Healthcare Company, to outsource some of its IT jobs of its Temecula facility has met with severe criticism with the state's political leadership. The facility currently employs 1,500 people. The company recently relieved 180 IT workers, in place of whom the present IT jobs have been outsourced to India

    According to The Press Enterprise
    , Sen. Durbin in a letter to the company's CEO, Mr. Miles White expressed his concern over the decision to turn out 180 IT workers and replace them with foreign hands.

    "To add insult to injury, the Abbott Labs IT staff who will be laid off will first be forced to train their replacements," he wrote in a letter that was posted on Cafepharma.com, a watercooler website frequented by workers in the healthcare industry.

    "It should go without saying that such harsh and insensitive conduct is not justified by whatever marginal financial benefit might accrue to your company, which is already making billions of dollars in profits every year."Mr. Durbin ended his letter asking the Abott CEO to restore the jobs of the American IT employees.

    Abbott spokesperson. Mr. John Koval revealed that the company had recently outsourced some "IT capabilities" and did not elaborate any further."Abbott regularly evaluates its competitive position and makes changes that reflect the strategic needs of its business. ... We’re retaining the vast majority of our U.S.-based IT jobs," he said.

    Last year the company had dropped 60% of its workforce , decreasing its strength from 4,000 to 1,500.















    Abbott LaboratoriesMr. Miles WhiteSen. Dick Durbin.Temecula
    Source : The Press Enterprise

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Geeta Sharma Sharma
    Geeta Sharma Sharma
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok